Ayşegül Öztürk

Dr. Ayşegül Öztürk


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 July 2022 in The European Research Journal
Verified
Journal Article
Open access
PDF file
KYKenan YILDIZHAN
Kenan YILDIZHAN
AÖAyşegül Öztürk
Ayşegül Öztürk
Objectives: Quipazine is a serotonin agonist. It is known that serotonin, an important neurotransmitter, contributes to the etiology of psychiatric and many neurodegenerative diseases. However, the effect of the serotonin agonist quipazine on HT-22 cells in glutamate-induced cytotoxicity is unknown. This study aims to investigate the effect of quipazine on increased oxidative stress (OS) as a result of glutamate-induced cytotoxicity in HT-22 cells.Methods: The cells were divided into 4 groups, Control group: no treatment was applied, Glutamate group: glutamate was incubated at 10 mM for 24 h, Quipazine group: incubated with different doses of quipazine for 24 h, Quipazine+Glutamate group were pre-treated with various concentrations (25, 50, 100 and 200 µM) of quipazine for 1 h and then exposed to 10 mM glutamate for 24 h. Cell viability rate between groups was measured by the XTT assay. OS and antioxidant levels were measured with the Total Oxidant Status (TOS) and Total Antioxidant Status (TAS) Elisa kits, and Caspase-3 levels were also examined in caspase activity.Results: Quipazine at different concentrations showed significant differences in cell viability in HT-22 cells. An appropriate dose of 25 µM was accepted for quipazine in the study. Quipazine treatment with glutamate-toxicity in the cells further reduced TAS levels and significantly increased TOS levels. It was also observed that the Caspase-3 level increased more in the Quipazine + Glutamate group according to the Glutamate group.Conclusions: The results determined that the use of quipazine is an agent that will further increase the neurodegeneration caused by glutamate toxicity.

30 May 2025 in Medical Oncology
Verified
Journal Article
Open access
PDF file
AÖAyşegül Öztürk
Ayşegül Öztürk
ZJZiad Joha
Ziad Joha
NBNeslihan Başgöz
Neslihan Başgöz
ATAhmet Şevki Taşkıran
Ahmet Şevki Taşkıran
Neuroblastoma, a childhood cancer, arises from neural crest cells within the sympathetic nervous system. This study investigated the anticancer effects of the exogenous hydrogen sulfide (H₂S) donor, sodium hydrogen sulfide (NaHS), on neuroblastoma cells, elucidating how it inhibits cell proliferation. The study was conducted using the SH-SY5Y cell line. The cells were exposed to various concentrations of NaHS (32, 16, 8, 4, and 2 mM) for 24 h. Cell viability was assessed using the XTT assay. ELISA was used to measure levels of the growth signal factors HER-2, EGFR, mTOR, ERK-1, and ERK-2, as well as the apoptosis marker caspase-3. In addition, apoptosis was evaluated using the Muse Annexin V & Dead Cell Assay Kit. NaHS significantly reduced cell proliferation, as demonstrated by the XTT assay (p < 0.001). NaHS treatment also decreased levels of HER-2, EGFR, ERK-1, and ERK-2 (p < 0.05 to p < 0.01), while mTOR levels remained unchanged (p > 0.05) and caspase-3 levels increased (p < 0.001). Flow cytometry confirmed that NaHS treatment significantly increased the proportion of apoptotic cells (p < 0.001). The antiproliferative effect of NaHS against neuroblastoma appears to be mediated through the suppression of certain growth signal factors and the induction of apoptosis. These findings suggest that exogenous hydrogen sulfide donors hold promise as a potential therapeutic strategy for neuroblastoma.

1 April 2025 in Journal of Boron
Verified
Journal Article
Open access
PDF file
AÖAyşegül Öztürk
Ayşegül Öztürk
ATAhmet Şevki Taşkıran
Ahmet Şevki Taşkıran
EGEmin Gündoğdu
Emin Gündoğdu
This study designed to investigate the biochemical changes in glial cells' oxidant/antioxidant systems in response to glutamate-induced excitotoxicity of boric acid (BA). The present study employed C6 glial cells. For the study, cells were separated into 4 groups as control, glutamate (10mM), glutamate+BA (0,23; 0,46; 0,93; 1,87 and 3,75 μg/mL), and BA (0,23; 0,46; 0,93; 1,87 and 3,75 μg/mL). The control group was not treated. The cells in the glutamate group were treated with 10 mM glutamate for 24 hours. BA was administered one hour prior to the addition of glutamate and incubated for 24 hours. The viability of the cells was evaluated using an XTT assay. Commercial kits were used for biochemical analyses. Significance was set at less than 0.05. The biochemical analysis revealed that the levels of malondialdehyde (MDA), nitric oxide (NO), inducible nitric oxide snythase (iNOS), neuronal nitric oxide synthase (nNOS), and total oxidant status (TOS) were elevated in the glutamate group compared to the control group (p

27 December 2022 in Cumhuriyet Science Journal
Verified
Journal Article
Open access
PDF file
AÖAyşegül Öztürk
Ayşegül Öztürk
VSVedat Sabancioğullari
Vedat Sabancioğullari
YTYaşar TAŞTEMUR
Yaşar TAŞTEMUR
IÖİbRahim Öztoprak
İbRahim Öztoprak
The neurological process in diabetes is not limited to peripheral nerves but also affects the central nervous system (CNS). In addition, magnetic resonance images (MRI) showing that this condition can occur early in the neuropathic process are also available. This study was conducted to investigate whether peripheral sensory nerve dysfunction causes changes in thalamus volume in patients with diabetic polyneuropathy (DPNP) who experience sensory loss. Our study is a retrospective study consisting of diabetes mellitus (DM), DPNP and a healthy control group, where brain MRI of 204 individuals aged between 20-90 with no neurological disorder that might affect thalamus. Morphometric measurements for thalamus and cerebrum volumetry were performed in conventional MRI. In order to measure the microstructural changes of thalamus, the apparent diffusion coefficient (ADC) was calculated by the diffusion-weighted imaging method. In conclusion of our measurements, it was found that individuals with DM and DPNP had a decrease in volume of both thalami(p<0.05) and cerebrum(p0.05). According to the results of research, DM and DPNP affect not only the peripheral nervous system but also the CNS. This effect caused atrophy of thalamus and cerebrum in patients of all age groups.

30 March 2026 in Türk Doğa ve Fen Dergisi
Verified
Journal Article
Closed access
AÖAyşegül Öztürk
Ayşegül Öztürk
BYBüşra Yıldız
Büşra Yıldız
HAHilmi Ataseven
Hilmi Ataseven
ZIZeynep Deniz Şahin İnAn
Zeynep Deniz Şahin İnAn
Aim: This study aimed to investigate the potential effects of pantoprazole on wound healing using the L929 fibroblast cell line. Specifically, its impact on cell viability, oxidative stress markers, and the in vitro wound healing process was evaluated.Material and Method: L929 fibroblast cells were treated with pantoprazole at concentrations between 2.5 and 40 μM for 24 hours to assess cell viability. To evaluate oxidative balance, 2.5 μM pantoprazole was applied, and total antioxidant status (TAS) and total oxidant status (TOS) were measured. For wound healing analysis, a scratch assay was performed by creating a standardized wound area (0.9 × 1.8 mm), and cell migration toward the wound was evaluated at 24-, 36-, and 48-hours post-treatment.Results: Pantoprazole showed a concentration-dependent cytotoxic effect at doses between 5 and 40 μM (p < 0.05 to p < 0.001), while 2.5 μM significantly enhanced cell viability (p < 0.01). TAS levels were significantly increased (p < 0.05), with no significant change in TOS (p > 0.05). Wound closure was significantly improved at 48 hours in the pantoprazole-treated group (p < 0.05), though earlier time points showed no statistical difference.Conclusion: At low concentrations, pantoprazole enhances fibroblast viability, boosts antioxidant status, and accelerates wound healing, indicating potential therapeutic utility in tissue repair and oxidative stress modulation.

26 March 2023 in Cumhuriyet Medical Journal
Verified
Journal Article
Open access
PDF file
AÇArzuhan çetindağ
Arzuhan çetindağ
AÖAyşegül Öztürk
Ayşegül Öztürk
Absract: The latest research have demonstrated that inflammation, oxidative stress and apoptosis plays a majör role in morphine analgesia and tolerance development. This search goals to examine the possible role of thiamine use on oxidative stress, inflammation and apoptosis in the development of morphine analgesia and morphine tolerance in rats. Methods: Thirty-six male Wistar rats were used in this study. The rats were severed into six groups: saline, 100 mg/kg thiamine, 5 mg/kg morphine, thiamine + morphine, morphine tolerance and thiamine + morphine tolerance. The resulting analgesic effect was measured by hot plate and tail movement analgesia tests. TAS and TOS, inflammation parameters, and apoptosis protein levels of the dorsal root ganglion tissues sample were measured using an ELISA kit. Results: When thiamine was given alone, it did not show anti-nociceptive effect (p>0.05). In addition, thiamine enhanced the analgesic effect of morphine (p < 0.05) and also significantly reduced tolerance to morphine (p < 0.05). However, it reduced TOS when administered with a single dose of morphine and tolerance induction (p < 0.05). In addition, thiamine reduced apoptosis protein levels after tolerance development (p < 0.05). Conclusion: Consequently, these results may attain by reducing TOS, inflammation, and apoptosis.